TechCrunch · Note ·
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
What moved
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Why it matters
Filed as a public note from TechCrunch, 2026-11-17. The desk tags this brief Medical / Science.
On the record
- Filed from the TechCrunch official RSS on 2026-11-17.
- Primary source host: techcrunch.com.
- Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Primary source
techcrunch.com
techcrunch.com
Desk
Logged as brief 11864
Logged as brief 11864
Cite this brief
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials (TechCrunch, 2026-11-17) — https://labledgerdesk.pages.dev/b/2026/11/17/isomorphic-labs-raises-5b-as-it-looks-to-take-drug-candidates-to/